Skip to main content

Table 1 Patients’ characteristics

From: Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DM

n   87
age years 65 (10)
diabetes duration years 15 (8)
male : female % 75 : 25
smoking §   38-47-15
body mass index kg.m-2 29.3 (5.9)
waist circumference cm 104 (15)
metabolic syndrome % 87
hypertension % 91
anti-dyslipidemic drug(s) % 90
statin-fibrate-ezetimibe % 74-43-2
HbA 1c mmol.mol-1 62 (11)
glomerular filtration rate mL.min-11.73m2 80 (32)
albuminuria μg.mg creatinine-1 67 (126)
total cholesterol mg.dL-1 161 (35)
LDL-cholesterol mg.dL-1 80 (30)
non-HDL-cholesterol mg.dL-1 113 (36)
HDL-cholesterol mg.dL-1 49 (15)
apoB 100 mg.dL-1 81 (23)
estimated apoB 100 (equation 1)* mg.dL-1 80 (23)
estimated apoB 100 (equation 2)** mg.dL-1 80 (22)
triglycerides mg.dL-1 169 (105)
atherogenic dyslipidemia % 49
coronary artery disease % 25
peripheral artery disease % 11
transient ischemic attack/stroke % 5
  1. Results are expressed as means (1 standard deviation) or proportions; apo, apolipoprotein; HbA 1c , glycated haemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; §: never-former-current; * : equation 1: apoB100(mg/dL) = [0.65 × non - HDL-cholesterol (mg/dL)] + 6.3 (mg/dL); * *: equation 2: apoB100(mg/dL) = − 33.12 (mg/dL) + [0.675 × LDL-cholesterol (mg/dL)] + [11.95 × ln[triglycerides] (mg/dL)].